🇺🇸 GKOS — Glaukos Corporation

Salud Compra fuerte
← Volver

Precio actual

246,70 USD

Máx. histórico

246,70

0 días

Caída desde máximo

En máximo

Rango 52 semanas

80,91 – 255,19

Variación hoy

+5,86%

Cierre anterior

233,04

Rango de hoy

235,95 – 255,19

Volumen hoy

2.074.592

Peor caída histórica

-69,57%

01/08/2019 → 20/03/2020

Recuperado en 299 días

Volatilidad anualizada ⓘ

54,28%

Información
Nombre completo
Glaukos Corporation
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Medical Devices
Empleados
1.094
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
242,46 USD (puede no estar actualizado)
Primera cotización
25/06/2015
Precio actualizado
hace 4 horas
Sobre la empresa

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor. The company also provides iStent infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. In addition, the company develops iLink, a device used for the treatment of keratoconus without the removal of the epithelium; ILution, a platform of cream-based drug formulation applied to the outer surface of the eyelid for drop less transdermal delivery of pharmaceutically active compounds for the treatment of anterior segment eye disorders; and retinal XR platform to treat age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and other posterior segment retinal diseases. It sells its products to ambulatory surgery centers, hospitals, and physician private practices through a direct sales organization, direct sales subsidiaries, and distributors. The company was formerly known as Transdx, Inc. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
16/02/2018 31,24 31,46 31,02 31,07 -0,67% 1,41% 179.900
15/02/2018 31,23 31,80 31,02 31,28 +0,87% 2,50% 274.600
14/02/2018 29,47 31,21 29,47 31,01 +4,45% 5,90% 393.000
13/02/2018 29,14 29,79 29,00 29,69 +1,19% 2,71% 271.700
12/02/2018 29,29 29,72 28,78 29,34 +0,96% 3,23% 199.000
09/02/2018 28,60 29,32 27,99 29,06 +2,29% 4,63% 299.500
08/02/2018 29,33 29,53 28,40 28,41 -2,90% 3,86% 327.900
07/02/2018 29,34 29,64 28,98 29,26 -0,88% 2,25% 237.700
06/02/2018 28,28 29,71 28,07 29,52 +1,93% 5,80% 445.600
05/02/2018 29,71 29,97 28,64 28,96 -3,18% 4,48% 410.300
02/02/2018 29,98 30,20 29,61 29,91 -0,80% 1,95% 268.300
01/02/2018 29,88 30,15 29,43 30,15 +0,47% 2,41% 321.400
31/01/2018 30,89 30,93 29,75 30,01 -2,60% 3,82% 261.500
30/01/2018 30,65 31,11 30,50 30,81 -1,00% 1,99% 325.800
29/01/2018 31,11 31,37 30,46 31,12 -0,54% 2,93% 460.400
26/01/2018 30,07 31,34 30,02 31,29 +5,14% 4,39% 513.400
25/01/2018 30,07 30,25 29,51 29,76 -0,70% 2,46% 568.100
24/01/2018 29,75 30,30 29,01 29,97 +1,05% 4,34% 1.048.300
23/01/2018 29,00 29,74 28,62 29,66 +2,28% 3,86% 553.500
22/01/2018 28,57 29,02 28,13 29,00 +1,61% 3,13% 359.900
19/01/2018 28,65 28,73 27,56 28,54 -0,04% 4,08% 514.000
18/01/2018 29,58 29,68 28,48 28,55 -3,61% 4,06% 1.111.600
17/01/2018 28,53 29,69 28,45 29,62 +4,04% 4,35% 781.700
16/01/2018 28,60 29,61 28,15 28,47 +0,49% 5,10% 555.700
12/01/2018 28,61 28,87 28,00 28,33 -0,81% 3,04% 434.700
11/01/2018 28,25 29,33 28,20 28,56 +1,28% 4,00% 665.200
10/01/2018 27,35 28,59 27,31 28,20 +3,26% 4,70% 504.900
09/01/2018 26,84 27,48 26,48 27,31 +1,94% 3,73% 337.800
08/01/2018 26,25 27,16 25,55 26,79 +2,06% 6,13% 312.000
05/01/2018 26,23 26,39 25,25 26,25 +0,77% 4,33% 411.500